TYRX has announced CMS issued a new ICD-9-CM procedure code for hospital reporting of the use of an antimicrobial envelope with insertion of cardiovascular implantable electronic devices, including pacemakers and implantable defibrillators.
TYRX developed the AIGISRx Antibacterial Envelope, designed to reduce surgical site infections associated with cardiovascular implantable electronic devices.
The procedure code 17.81 will allow providers to track the clinical and economic impact of treating patients with a device intended to securely hold an implantable pacemaker or defibrillator in place while delivering site-specific antibiotic prophylaxis to help reduce infection.
Learn more about TYRX.
TYRX developed the AIGISRx Antibacterial Envelope, designed to reduce surgical site infections associated with cardiovascular implantable electronic devices.
The procedure code 17.81 will allow providers to track the clinical and economic impact of treating patients with a device intended to securely hold an implantable pacemaker or defibrillator in place while delivering site-specific antibiotic prophylaxis to help reduce infection.
Learn more about TYRX.